Trials / Completed
CompletedNCT01094847
Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- Male
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare and explore bioavailability of mosapride, the main component of DWJ1252(Test drug) and mosapride medicine(Reference drug).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWJ1252 | tablet(oral) administration following the schedule of each arm |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-05-01
- First posted
- 2010-03-29
- Last updated
- 2011-05-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01094847. Inclusion in this directory is not an endorsement.